Is fourth-line chemotherapy routine practice in advanced non-small cell lung cancer?. Issue 2 (February 2015)

• Record Type: Journal Article
• Authors: Choi, Yong Won; Ahn, Mi Sun; Jeong, Geum Sook; Lee, Hyun Woo; Jeong, Seong Hyun; Kang, Seok Yun; Park, Joon Seong; Choi, Jin-Hyuk; Lee, Soon Young
• Is Part Of: Lung cancer. Volume 87:Issue 2(2015:Feb.)
• Page Start: 155
• Page End: 161
• Publication Date: 2015-02
• Subjects: Lungs -- Cancer -- Periodicals; Lung Neoplasms -- Abstracts; Lung Neoplasms -- Periodicals; Poumons -- Cancer -- Périodiques; Lungs -- Cancer; Periodicals; Electronic journals; Electronic journals; 616.99424
• DOI: 10.1016/j.lungcan.2014.11.016
• Languages: English
• ISSNs: 0169-5002

Abstract

<abstract abstract-type="author-highlights" id="abs0005"> <title id="sect0005">Highlights</title> <sec> <p id="spar0080"> <list id="lis0005"> <list-item id="lsti0005"> <label></label> <p id="par0005">Fourth-line therapy in advanced NSCLC is clinical practice in some countries.</p> </list-item> <list-item id="lsti0010"> <label></label> <p id="par0010">Median overall survival after the start of fourth-line therapy was 9 months.</p> </list-item> <list-item id="lsti0015"> <label></label> <p id="par0015">Good performance status was favorable prognostic factor after fourth-line therapy.</p> </list-item> <list-item id="lsti0020"> <label></label> <p id="par0020">Disease control after first-line therapy was associated with favorable outcome.</p> </list-item> </list> </p> </sec> </abstract>